2011-12-232011-12-232011http://hdl.handle.net/10625/47914The table of contents for this item can be shared with the requester. The requester may then choose one chapter, up to 10% of the item, as per the Fair Dealing provision of the Canadian Copyright ActThe analysis suggests that local firms in developing countries are better supported in a framework where patent protection for minor incremental innovations is not allowed. The study also suggests that with the application of well-defined patentability standards, governments could avoid spending the political capital necessary to grant and sustain compulsory licenses. Patents over minor incremental developments (‘evergreening’ patents) may be used to exclude generic competition, blocking access to affordable drugs. If patent applications were correctly scrutinized, there would be no need to have recourse to such measures.Text1 digital file (37 p. : ill.)enPHARMACEUTICAL INDUSTRYCOMPULSORY LICENSEEVERGREENINGACCESS TO MEDICINECOMPETITION POLICYINTELLECTUAL PROPERTYPATENTSINNOVATION SYSTEMSDEVELOPING COUNTRIESLOCAL INDUSTRYLICENSINGGLOBAL SOUTHLOCAL INDUSTRYLICENSINGGLOBAL SOUTHARGENTINACOLOMBIABRAZILINDIASOUTH AFRICAIDRC-Related Report